Search by Drug Name or NDC
NDC 53002-1425-00 Buspirone Hydrochloride 30 mg/1 Details
Buspirone Hydrochloride 30 mg/1
Buspirone Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is BUSPIRONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Buspirone is used to treat anxiety disorders or in the short-term treatment of symptoms of anxiety. Buspirone is in a class of medications called anxiolytics. It works by changing the amounts of certain natural substances in the brain.
Related Packages: 53002-1425-00Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Buspirone
Product Information
| NDC | 53002-1425 |
|---|---|
| Product ID | 53002-1425_718b1086-bf8e-4b96-8794-e5e0fc641003 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Buspirone Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Buspirone Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | BUSPIRONE HYDROCHLORIDE |
| Labeler Name | RPK Pharmaceuticals, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075022 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 53002-1425-00 (53002142500)
| NDC Package Code | 53002-1425-0 |
|---|---|
| Billing NDC | 53002142500 |
| Package | 100 TABLET in 1 BOTTLE (53002-1425-0) |
| Marketing Start Date | 2022-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |